ClinicalTrials.Veeva

Menu

Theta Burst Stimulation for Motor Recovery

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

Transcranial Magnetic Stimulation

Treatments

Device: repetitive transcranial magnetic stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05613686
202204105DINB

Details and patient eligibility

About

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. This study will compare efficacy of different doses iTBS in combination with inhibitory rTMS on motor recovery and cortical excitability in subacute stroke patients.

Full description

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology.

High and low frequencies of rTMS could modulate the excitability of the cerebral cortex. Theta burst stimulation (TBS) has achieved a similar effect to traditional rTMS mode. Intermittent TBS (iTBS) could upregulate cortical excitability of the primary motor cortex (M1) and continuous TBS (cTBS) with inhibitory effect. Through modulating the excitability of bilateral hemispheres, rTMS could facilitate motor recovery in stroke patients.

This study will compare efficacy of different doses iTBS in combination with inhibitory rTMS on motor recovery and cortical excitability in subacute stroke patients.

Enrollment

60 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1.Unilateral ischemic or hemorrhagic stroke
  • 2.Stroke within 3 months
  • 3.Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
  • 4.No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
  • 5.Patient could sit over 15 minutes
  • 6.Age over 20

Exclusion criteria

  • 1.Previous stroke, traumatic brain injury, brain tumor
  • 2.With central nervous system disease (spinal cord injury, Parkinson's disease)
  • 3.Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
  • 4.Patients unable to cooperate the treatment
  • 5.Pregnancy
  • 6.Depression

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

contralateral 1Hz+ipsilateral iTBS 1
Experimental group
Description:
Patients received contralateral 1 Hz and ipsilateral iTBS with protocol 1
Treatment:
Device: repetitive transcranial magnetic stimulation
contralateral 1Hz+ipsilateral iTBS 2
Experimental group
Description:
Patients received contralateral 1 Hz and ipsilateral iTBS with protocol 2
Treatment:
Device: repetitive transcranial magnetic stimulation
contralateral 1Hz
Active Comparator group
Description:
Patients received contralateral 1 Hz and ipsilateral sham iTBS
Treatment:
Device: repetitive transcranial magnetic stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Ming Yen Hsiao, M.D., PhD; Meng Ting Lin, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems